Accordingly, the development of diagnostic and/or therapeutic tools targeting aberrant mitochondrial dynamics may lead to a preferable result for cardiac insulin resistance, which may contribute to a better prognosis of HF. The gene discussed is INS; the disease is hydrops fetalis.